Literature DB >> 21863279

Survival, but not maturation, is affected in neutrophil progenitors from GSD-1b patients.

Gepke Visser1, Wilco de Jager, Liesbeth P Verhagen, G Peter A Smit, Frits A Wijburg, Berent J Prakken, Paul J Coffer, Miranda Buitenhuis.   

Abstract

Glycogen storage disease type 1b (GSD 1b) is caused by mutations in the Glucose-6-phosphate transporter and is characterized by impaired glucose homeostasis. In addition, GSD-1b is associated with chronic neutropenia resulting in recurrent infections and inflammatory bowel disease. It is unclear whether the neutropenia is solely due to enhanced apoptosis of mature neutrophils or whether aberrant neutrophil development may also contribute. Here we demonstrate that hematopoietic progenitors from GSD-1b patients are not impaired in their capacity to develop into mature neutrophils. However, optimal survival of neutrophil progenitors from GSD-1b patients requires high glucose levels (> 200 mg dl(-1)), suggesting that even under normoglycemic conditions these cells are more prone to apoptosis. Furthermore, analysis of cytokine levels in peripheral blood suggests an inflammatory state with an inverse correlation between the level of inflammation and the number of neutrophils. Finally, in some patients, with low numbers of peripheral blood neutrophils, high numbers of neutrophils were observed in the intestine. Together, these results suggest that the neutropenia observed in GSD-1b patients is not caused by impaired maturation, but may be caused by both increased levels of apoptosis and egress of neutrophils from the blood to the inflamed tissues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21863279     DOI: 10.1007/s10545-011-9379-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  31 in total

1.  Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).

Authors:  Jan Peter Rake; Gepke Visser; Philippe Labrune; James V Leonard; Kurt Ullrich; G Peter A Smit
Journal:  Eur J Pediatr       Date:  2002-08-22       Impact factor: 3.183

2.  Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies.

Authors:  Wilco de Jager; Berent J Prakken; Johannes W J Bijlsma; Wietse Kuis; Ger T Rijkers
Journal:  J Immunol Methods       Date:  2005-05       Impact factor: 2.303

3.  Bone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functions.

Authors:  So Youn Kim; Andrew D Nguyen; Ji-Liang Gao; Philip M Murphy; Brian C Mansfield; Janice Yang Chou
Journal:  J Biol Chem       Date:  2006-08-04       Impact factor: 5.157

4.  A convenient diagnostic function test of peripheral blood neutrophils in glycogen storage disease type Ib.

Authors:  A J Verhoeven; G Visser; R van Zwieten; B Gruszczynska; D W Tien Poll-The; G P Smit
Journal:  Pediatr Res       Date:  1999-06       Impact factor: 3.756

5.  Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b.

Authors:  Rosanna Leuzzi; Gábor Bánhegyi; Tamás Kardon; Paola Marcolongo; Piero-Leopoldo Capecchi; Hans-Joerg Burger; Angelo Benedetti; Rosella Fulceri
Journal:  Blood       Date:  2002-11-07       Impact factor: 22.113

6.  Intestinal function in glycogen storage disease type I.

Authors:  G Visser; J P Rake; F T M Kokke; P G J Nikkels; P J J Sauer; G P A Smit
Journal:  J Inherit Metab Dis       Date:  2002-08       Impact factor: 4.982

7.  Evidence for the participation of independent translocation for phosphate and glucose 6-phosphate in the microsomal glucose-6-phosphatase system. Interactions of the system with orthophosphate, inorganic pyrophosphate, and carbamyl phosphate.

Authors:  W J Arion; A J Lange; H E Walls; L M Ballas
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

8.  Crosstalk between CXCR4/stromal derived factor-1 and VLA-4/VCAM-1 pathways regulates neutrophil retention in the bone marrow.

Authors:  Joseph M Petty; Christopher C Lenox; Daniel J Weiss; Matthew E Poynter; Benjamin T Suratt
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

9.  Improved neutrophil function in a glycogen storage disease type 1b patient after liver transplantation.

Authors:  Masanori Adachi; Masato Shinkai; Youkatsu Ohhama; Katsuhiko Tachibana; Tadatoshi Kuratsuji; Hiroh Saji; Etsuko Maruya
Journal:  Eur J Pediatr       Date:  2004-02-11       Impact factor: 3.183

10.  Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.

Authors:  Wilco de Jager; Katarzyna Bourcier; Ger T Rijkers; Berent J Prakken; Vicki Seyfert-Margolis
Journal:  BMC Immunol       Date:  2009-09-28       Impact factor: 3.615

View more
  7 in total

Review 1.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

Review 2.  Glycogen metabolism and glycogen storage disorders.

Authors:  Shibani Kanungo; Kimberly Wells; Taylor Tribett; Areeg El-Gharbawy
Journal:  Ann Transl Med       Date:  2018-12

3.  Vitamin E Improves Clinical Outcome of Patients Affected by Glycogen Storage Disease Type Ib.

Authors:  Daniela Melis; Giorgia Minopoli; Francesca Balivo; Paola Marcolongo; Rossella Parini; Sabrina Paci; Carlo Dionisi-Vici; Roberto Della Casa; Angelo Benedetti; Generoso Andria; Giancarlo Parenti
Journal:  JIMD Rep       Date:  2015-06-30

4.  Development and characterization of an inducible mouse model for glycogen storage disease type Ib.

Authors:  Federica Raggi; Anna Livia Pissavino; Roberta Resaz; Daniela Segalerba; Andrea Puglisi; Cristina Vanni; Francesca Antonini; Genny Del Zotto; Alessandra Gamberucci; Paola Marcolongo; Maria Carla Bosco; Federica Grillo; Luca Mastracci; Alessandra Eva
Journal:  J Inherit Metab Dis       Date:  2018-07-02       Impact factor: 4.982

Review 5.  Liver transplantation in glycogen storage disease type I.

Authors:  Susanna J B Boers; Gepke Visser; Peter G P A Smit; Sabine A Fuchs
Journal:  Orphanet J Rare Dis       Date:  2014-04-09       Impact factor: 4.123

6.  Sodium-glucose cotransporter type 2 channel inhibitor: Breakthrough in the treatment of neutropenia in patients with glycogen storage disease type 1b?

Authors:  Magdalena Kaczor; Milena Greczan; Karolina Kierus; Ewa Ehmke Vel Emczyńska-Seliga; Elżbieta Ciara; Barbara Piątosa; Dariusz Rokicki; Janusz Książyk; Dorota Wesół-Kucharska
Journal:  JIMD Rep       Date:  2022-03-02

7.  A case of secondary acute myeloid leukemia on a background of glycogen storage disease with chronic neutropenia treated with granulocyte colony stimulating factor.

Authors:  Dina Khalaf; Heather Bell; David Dale; Vikas Gupta; Hanna Faghfoury; Chantal F Morel; Anne Tierens; David A Weinstein; Jiong Yan; Santhosh Thyagu; Dawn Maze
Journal:  JIMD Rep       Date:  2019-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.